Menu

Longevity guide · 2 min read

NAD+ and Sermorelin act on different systems. They are not swaps.

The short answer

NAD+ is a coenzyme involved in cell energy and repair. Sermorelin is a hormone analog that prompts the pituitary to release growth hormone. They work on different systems, so they are not substitutes. Both have limited human evidence for longevity goals. Compounded versions of both are not FDA-approved. A licensed clinician should weigh goals, history and labs.

Livozo expects to offer clinician-reviewed access to NAD+, Sermorelin and B12 through a licensed clinical partner. Care is not live today. This guide does not recommend a specific treatment.

Different mechanisms

NAD+ takes part in energy metabolism and supports enzymes that repair DNA. Interest in NAD+ comes from the finding that levels tend to fall with age.[1]

Sermorelin acts on the growth hormone system. It signals the pituitary gland to release growth hormone, and the body's feedback system still shapes that release.[2]

Different evidence gaps

For NAD+, human studies of injections are small and mostly measure blood levels, not health outcomes. Much remains unknown about how NAD+ affects human aging.[1]

For Sermorelin, a 2020 review found that clinical data are largely lacking. Neither treatment has large, long-term trials showing longevity benefits.[3]

Different questions for a clinician

With NAD+, ask about the route, how often it is used and how you will judge whether it helps. With Sermorelin, ask which baseline labs you need, such as IGF-1, and how often they will be repeated.

For both, ask what goal the treatment serves, what the evidence shows for that goal and when you would stop. Compounded versions of both are not FDA-approved.[4]

Current Livozo status

Livozo expects to offer clinician-reviewed access to both through a licensed clinical partner. Care is not live, and neither can be bought or prescribed through this site today. A partner clinician, not Livozo, would decide whether either one is appropriate.

What we know

  • NAD+ and Sermorelin act on different biological systems.
  • NAD+ levels tend to fall with age. Sermorelin prompts growth hormone release.
  • Neither has strong long-term human evidence for longevity goals.

What we don't know yet

  • Whether either treatment extends healthy lifespan in people.
  • Whether using both together offers any added benefit or added risk.
  • Which people are most likely to benefit from either one.

Safety

  • Do not treat one as a substitute for the other. Their risks and review steps differ.
  • Tell the clinician about all medicines, supplements and health conditions.
  • Seek urgent care for signs of a serious allergic reaction after any injection.

This guide is education, not medical advice. It does not create a clinician-patient relationship. If you think you are having an emergency, call 911.

Sources

  1. Covarrubias et al. — NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol, 2021
  2. Walker — Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? (editorial). Clin Interv Aging, 2006
  3. Sinha et al. — Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Transl Androl Urol, 2020
  4. FDA — Human drug compounding

Keep reading.